Saturday, April 28, 2007

Clinical Trials: Multiple Sclerosis


Arizona

Phoenix; Hope Research Institute, LLC
Do you have Multiple Sclerosis?

Phoenix; Hope Research Institute, LLC
Are you an adult who has been diagnosed with Multiple Sclerosis?

Phoenix; Barrow Neurological Institute
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

Tucson; Northwest NeuroSpecialists, PLLC
Multiple Sclerosis Study

Tucson; Northwest NeuroSpecialists, PLLC
Clinical Research Study Available for People Diagnosed with Multiple Sclerosis

California

Duarte; City of Hope
A Phase I/II Study of High-Dose Immunosuppressive Therapy (HDIT) Using Carmustine, Etoposide, Cytarabine and Melphalan (BEAM) + Thymoglobulin and Autologous CD34 + Hematopoietic Stem Cell Transplant (HCT) for the Treatment of Poor Prognosis Multiple Sclerosis

La Jolla; Coordinated Clinical Research (La Jolla, CA)
Do you have Relapsing-Remitting Multiple Sclerosis

Los Angeles; UCLA Medical Center
Multiple Sclerosis Research Study in Women after Pregnancy

Los Angeles; UCLA Medical Center
Multiple Sclerosis Research Study in Pregnancy

Los Angeles; UCLA Medical Center
M.S Volunteers Needed for Research Study

Los Angeles; UCLA Medical Center
Multiple Sclerosis Research Study in Pregnancy

Los Angeles; UCLA Medical Center
Robotic Locomotor Training in Persons with Multiple Sclerosis

Los Angeles; Keck School of Medicine
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

San Francisco; University of California, San Francisco MS Center
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

Connecticut

New Haven; Yale MS Research Center
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

Florida

Aventura; South Florida Medical Research
Clinical Trial to evaluate the effectiveness of an approved medication to treat Multiple Sclerosis Pain.

Bradenton; Bradenton Research
Bradenton Neurology, Inc. is participating in a nationwide research study for individuals who have been diagnosed with Multiple Sclerosis.

Gainesville; Florida Medical Research Institute
MULTIPLE SCLEROSIS?

Plantation; Neurology Clinical Research, Inc.
Do you or a loved one have Multiple Sclerosis?

Sarasota; The Roskamp Institute, Clinical Trials Division[*]
Phase III study comparing different doses of study drug with placebo for Relapsing Remitting Multiple Sclerosis (RRMS)

Sarasota; The Roskamp Institute, Clinical Trials Division[*]
Phase III study for patients with Relapsing remitting Multiple Sclerosis

Sarasota; Lovelace Scientific Resources - Sarasota
Multiple Sclerosis
Do you have a diagnosis of Multiple Sclerosis?

Sarasota; Lovelace Scientific Resources - Sarasota
Multiple Sclerosis

Sarasota; The Roskamp Institute, Clinical Trials Division
Do you or a loved one have relapsing remitting multiple sclerosis?

Kansas

Kansas City; University of Kansas Medical Center Research Institute
A study to establish the safety and effectiveness of Interferon Beta- 1b and Interferon-1a combination injections (either under the skin or into the muscle) in subjects with relapsing-remitting multiple sclerosis (MS) who were previously treated with Beta Interferon-1a.

Lenexa; MidAmerica Neuroscience Institute
Do you have Relapsing Remitting Multiple Sclerosis?

Kentucky

Lexington; University of Kentucky Chandler Medical Center
Volunteers Needed for Multiple Sclerosis Research Study #2

Lexington; University of Kentucky Chandler Medical Center
Volunteers Needed for Multiple Sclerosis Research Study #1

Maryland

Baltimore; Johns Hopkins University
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

Missouri

St. Louis; Washington University Multiple Sclerosis Center
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

Nevada

Henderson; Nevada Neurological Consultants, Ltd.
Participants needed for a research study in Multiple Sclerosis

New York

Albany; Upstate Clinical Research, LLC
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Subcutaneous TovaxinTM in Subjects with Clinically Isolated Syndrome or Relapsing-Remitting Multiple Sclerosis�. (TERMS Study)

Buffalo; Jacobs Neurological Institute
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

New York; Mount Sinai Medical Center
A 24-month, double-blind, randomized, multi-center, placebo-controlled, parallel-group study comparing the efficacy and safety of FTY720 1.25mg and 0.5mg administered once daily versus placebo in patients with relapsing remitting multiple sclerosis

New York; Biomedical Research Alliance of New York
Relapsing - Remitting Multiple Sclerosis (RRMS)

New York; Mount Sinai Medical Center
The Establishment of a Patient Registry and Initiation of Related Projects of the New York State Multiple Sclerois Consortium

New York; Mount Sinai Medical Center
A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon beta 1-a and Glatiramer Acetate to Either Agent Alone in Patients with Relapsing-Remitting Multiple Sclerosis (CombiRx Phase III)

New York; Mount Sinai Medical Center
ITN020AI: A Randomized, Double Blind, Placebo Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of Atorvastatin in Patient with Clinically Isolated Syndrome and High Risk of Conversion to Multiple Sclerosis (MS) (STAYCIS)

New York; Mount Sinai Medical Center
A 21 WEEK STUDY TO EVALUATE SAFETY AND EFFICACY OF ORAL FAMPRIDINE-SR IN SUBJECTS WITH MULTIPLE SCLEROSIS.

New York; Mount Sinai School of Medicine
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

New York; Mount Sinai Medical Center
OMEGA-Oral Megadose Corticosteroid Therapy of Acute Exacerbations in Multiple Sclerosis

New York; Mount Sinai Medical Center
A Phase II/III, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multi-Center Study to Evaluate the Safety and Efficacy of Rituximab in Adults with Primary Progressive Multiple Sclerosis PROTOCOL: U2786g

Rochester; University of Rochester
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

North Carolina

Salisbury; Central Carolina Neurology & Sleep, PA
Looking for MS Patients for a Quality of Life Study

Ohio

Cleveland; Cleveland Clinic Foundation
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

Oregon

Portland; Oregon Health Sciences University
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

Texas

Dallas; University of Texas Southwestern Medical Center
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

Virginia

Charlottesville; University of Virginia
Men and Women 18-55 wanted for MS treatment trial

Washington

Seattle; Virginia Mason MS Center
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome

Tacoma; Charles River Laboratories Clinical Services - Northwest Kinetics
Research Study: Adults with Relapsing Forms of Multiple Sclerosis

International

Montreal, QC, Canada; Montreal Neurological Institute (MNI)
Statins to delay or prevent Multiple Sclerosis in patients experiencing a Clinically Isolated Syndrome


http://www.centerwatch.com/patient/studies/cat102.html

0 Comments:

Post a Comment

<< Home